Considerations for the care of transgender patients in orthopaedics and sports medicine: a narrative review.
Br J Sports Med
; 58(18): 1075-1082, 2024 Sep 09.
Article
em En
| MEDLINE
| ID: mdl-38997148
ABSTRACT
Orthopaedic and sports medicine clinicians can improve outcomes for transgender patients by understanding the physiological effects of gender-affirming hormone therapy (GAHT). This narrative review investigated the role of GAHT on bone mineral density, fracture risk, thromboembolic risk, cardiovascular health and ligament/tendon injury in this population. A search from the PubMed database using relevant terms was performed. Studies were included if they were levels 1-3 evidence. Due to the paucity of studies on ligament and tendon injury risk in transgender patients, levels 1-3 evidence on the effects of sex hormones in cisgender patients as well as basic science studies were included for these two topics. This review found that transgender patients on GAHT have an elevated fracture risk, but GAHT has beneficial effects on bone mineral density in transgender women. Transgender women on GAHT also have an increased risk of venous thromboembolism, stroke and myocardial infarction compared with cisgender women. Despite these elevated risks, studies have found it is safe to continue GAHT perioperatively for both transgender women and men undergoing low-risk operations. Orthopaedic and sports medicine clinicians should understand these unique health considerations for equitable patient care.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Medicina Esportiva
/
Densidade Óssea
/
Pessoas Transgênero
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article